These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8394090)

  • 1. Antigenemia, immunoblotting, and enzyme immunoassay for early diagnosis of cytomegalovirus infection in renal transplant patients.
    Fischer L; Rautenberg P; Bienengräber H; Leimenstoll G
    Transpl Int; 1993; 6(4):201-5. PubMed ID: 8394090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients.
    Bein G; Bitsch A; Hoyer J; Steinhoff J; Fricke L; Machnik H; Dennin R; Kirchner H
    Transpl Int; 1993; 6(4):185-90. PubMed ID: 8394089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a novel immunoglobulin A capture enzyme immunoassay for diagnosis of cytomegalovirus infection in renal and heart transplant recipients.
    Rautenberg P; Fischer L; Tönnies R; Franke D
    Eur J Clin Microbiol Infect Dis; 1997 Sep; 16(9):653-9. PubMed ID: 9352258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of two novel enzyme immunoassays using recombinant antigens to detect cytomegalovirus-specific immunoglobulin M in sera from pregnant women.
    Daiminger A; Bäder U; Eggers M; Lazzarotto T; Enders G
    J Clin Virol; 1999 Aug; 13(3):161-71. PubMed ID: 10443792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients.
    van den Berg AP; van der Bij W; van Son WJ; Anema J; van der Giessen M; Schirm J; Tegzess AM; The TH
    Transplantation; 1989 Dec; 48(6):991-5. PubMed ID: 2556817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
    Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
    J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
    Halwachs-Baumann G; Wilders-Truschnig M; Enzinger G; Eibl M; Linkesch W; Dornbusch HJ; Santner BI; Marth E; Kessler HH
    J Clin Virol; 2001 Jan; 20(1-2):49-57. PubMed ID: 11163583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the AmpliSensor PCR and the SHARP signal detection system for the early prediction of symptomatic CMV infection in solid transplant recipients.
    Rautenberg P; Lübbert C; Weers W; Boetel E; Schweichler J; Zhou L; Costard-Jäckle A; Kraemer-Hansen H; Harder TC
    J Clin Virol; 1999 Jun; 13(1-2):81-94. PubMed ID: 10405895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice.
    Halwachs G; Zach R; Pogglitsch H; Holzer H; Tiran A; Iberer F; Wasler A; Tscheliessnigg HP; Lanzer G; Fölsch B
    Transplantation; 1993 Aug; 56(2):338-42. PubMed ID: 8395099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer.
    Maine GT; Stricker R; Schuler M; Spesard J; Brojanac S; Iriarte B; Herwig K; Gramins T; Combs B; Wise J; Simmons H; Gram T; Lonze J; Ruzicki D; Byrne B; Clifton JD; Chovan LE; Wachta D; Holas C; Wang D; Wilson T; Tomazic-Allen S; Clements MA; Wright GL; Lazzarotto T; Ripalti A; Landini MP
    J Clin Microbiol; 2000 Apr; 38(4):1476-81. PubMed ID: 10747129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation.
    Tanabe K; Tokumoto T; Ishikawa N; Koyama I; Takahashi K; Fuchinoue S; Kawai T; Koga S; Yagisawa T; Toma H; Ota K; Nakajima H
    Transplantation; 1997 Dec; 64(12):1721-5. PubMed ID: 9422409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two Cobas Core enzyme immunoassays with other test systems for the detection of cytomegalovirus-specific IgG and IgM antibodies.
    Steinmann J; Weigel T
    J Clin Lab Anal; 1994; 8(4):191-9. PubMed ID: 7931812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serology, antigenemia assay and the polymerase chain reaction for monitoring active cytomegalovirus infections in hematopoietic stem cell transplantation patients.
    Bonon SH; Rossi CL; de Souza CA; Vigorito AC; Costa SC
    Rev Inst Med Trop Sao Paulo; 2006; 48(5):275-8. PubMed ID: 17086316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. A study of kidney graft recipients developing a primary or recurrent CMV infection.
    Basson J; Tardy JC; Aymard M
    Arch Virol; 1989; 108(3-4):259-70. PubMed ID: 2557810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytomegalovirus infection in patients after kidney transplantation].
    Nouza M; Korcáková L
    Cas Lek Cesk; 1996 Jul; 135(14):454-7. PubMed ID: 8925546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to human cytomegalovirus structural polypeptides during primary infection.
    Landini MP; Rossier E; Schmitz H
    J Virol Methods; 1988 Dec; 22(2-3):309-17. PubMed ID: 2851606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.
    Prince HE; Lapé-Nixon M; Brenner A; Pitstick N; Couturier MR
    Clin Vaccine Immunol; 2014 Jun; 21(6):813-6. PubMed ID: 24671558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation.
    van den Berg AP; Klompmaker IJ; Haagsma EB; Scholten-Sampson A; Bijleveld CM; Schirm J; van der Giessen M; Slooff MJ; The TH
    J Infect Dis; 1991 Aug; 164(2):265-70. PubMed ID: 1649873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.